173 related articles for article (PubMed ID: 24515658)
1. Impact of vascular endothelial growth factor expression on overall survival in patients with osteosarcoma: a meta-analysis.
Zhuang Y; Wei M
Tumour Biol; 2014 Mar; 35(3):1745-9. PubMed ID: 24515658
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma.
Chen D; Zhang YJ; Zhu KW; Wang WC
Tumour Biol; 2013 Jun; 34(3):1895-9. PubMed ID: 23589053
[TBL] [Abstract][Full Text] [Related]
3. The role of vascular endothelial growth factor as a prognostic and clinicopathological marker in osteosarcoma: a systematic review and meta-analysis.
Zhang C; Wang L; Xiong C; Zhao R; Liang H; Luo X
J Orthop Surg Res; 2021 Dec; 16(1):738. PubMed ID: 34963495
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis.
Yu XW; Wu TY; Yi X; Ren WP; Zhou ZB; Sun YQ; Zhang CQ
Tumour Biol; 2014 Jan; 35(1):155-60. PubMed ID: 23907576
[TBL] [Abstract][Full Text] [Related]
5. Comment on Zhuang YF et al.: impact of vascular endothelial growth factor expression on overall survival in patients with osteosarcoma: a meta-analysis.
Ma J; Fang L; Zhang F
Tumour Biol; 2014 Sep; 35(9):8533-4. PubMed ID: 25113255
[No Abstract] [Full Text] [Related]
6. Prognostic significance of p53 expression in malignant bone tumors: a meta-analysis.
Jiang L; Tao C; He A
Tumour Biol; 2013 Apr; 34(2):1037-43. PubMed ID: 23341181
[TBL] [Abstract][Full Text] [Related]
7. Does serum alkaline phosphatase level really indicate the prognosis in patients with osteosarcoma? A meta-analysis.
Gu R; Sun Y
J Cancer Res Ther; 2018 Jun; 14(Supplement):S468-S472. PubMed ID: 29970708
[TBL] [Abstract][Full Text] [Related]
8. Expression and significance of TGF-beta isoform and VEGF in osteosarcoma.
Jung ST; Moon ES; Seo HY; Kim JS; Kim GJ; Kim YK
Orthopedics; 2005 Aug; 28(8):755-60. PubMed ID: 16119739
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis of alkaline phosphatase and prognosis for osteosarcoma.
Hao H; Chen L; Huang D; Ge J; Qiu Y; Hao L
Eur J Cancer Care (Engl); 2017 Sep; 26(5):. PubMed ID: 27349943
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study.
Tabone MD; Brugières L; Piperno-Neumann S; Selva MA; Marec-Bérard P; Pacquement H; Lervat C; Corradini N; Gentet JC; Couderc R; Chevance A; Mahier-Ait Oukhatar C; Entz-Werle N; Blay JY; Le Deley MC
BMC Cancer; 2017 Jun; 17(1):419. PubMed ID: 28619014
[TBL] [Abstract][Full Text] [Related]
11. Transferrin receptor-1 and VEGF are prognostic factors for osteosarcoma.
Wu H; Zhang J; Dai R; Xu J; Feng H
J Orthop Surg Res; 2019 Sep; 14(1):296. PubMed ID: 31484533
[TBL] [Abstract][Full Text] [Related]
12. Effects of vascular endothelial growth factor expression on pathological characteristics and prognosis of osteosarcoma.
Han G; Wang Y; Bi W; Jia J; Wang W; Xu M
Clin Exp Med; 2016 Nov; 16(4):577-584. PubMed ID: 26319790
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of elevated vascular endothelial growth factor in patients with osteosarcoma: a meta-analysis and systemic review.
Qu JT; Wang M; He HL; Tang Y; Ye XJ
J Cancer Res Clin Oncol; 2012 May; 138(5):819-25. PubMed ID: 22274866
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of serum lactate dehydrogenase level in osteosarcoma: a meta-analysis.
Chen J; Sun MX; Hua YQ; Cai ZD
J Cancer Res Clin Oncol; 2014 Jul; 140(7):1205-10. PubMed ID: 24682390
[TBL] [Abstract][Full Text] [Related]
15. Correlation of vascular endothelial growth factor with survival and pathological characteristics of patients with osteosarcoma: A systematic review and meta-analysis.
Xin S; Wei G
Eur J Cancer Care (Engl); 2022 Sep; 31(5):e13629. PubMed ID: 35707976
[TBL] [Abstract][Full Text] [Related]
16. Relationships between levels of CXCR4 and VEGF and blood-borne metastasis and survival in patients with osteosarcoma.
Lin F; Zheng SE; Shen Z; Tang LN; Chen P; Sun YJ; Zhao H; Yao Y
Med Oncol; 2011 Jun; 28(2):649-53. PubMed ID: 20349215
[TBL] [Abstract][Full Text] [Related]
17. Investigating the Relationship between of Vascular Endothelial Growth Factor and HER-2neu in IHC Staining with Metastasis and Mortality in Patients with Osteosarcoma.
Aznab M; Khajevand Ahmady M; Jamshidi K; Madani SH; Khazaei S; Shoushtaryzadeh T; Bagheri A
Asian Pac J Cancer Prev; 2020 Oct; 21(10):3005-3009. PubMed ID: 33112560
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis.
Wen X; Liu H; Yu K; Liu Y
Tumour Biol; 2014 Jan; 35(1):845-8. PubMed ID: 24037915
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor expression in osteosarcoma.
Charity RM; Foukas AF; Deshmukh NS; Grimer RJ
Clin Orthop Relat Res; 2006 Jul; 448():193-8. PubMed ID: 16826116
[TBL] [Abstract][Full Text] [Related]
20. Role of vascular endothelial growth factor as a tumour marker in osteosarcoma: a prospective study.
Rastogi S; Kumar R; Sankineani SR; Marimuthu K; Rijal L; Prakash S; Jalan D; Khan SA; Sharma MC
Int Orthop; 2012 Nov; 36(11):2315-21. PubMed ID: 23015149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
